Potential markers and metabolic processes involved in the mechanism of radiation-induced heart injury
Jan Slezak,Branislav Kura,Pavel Babal,Miroslav Barancik,Miroslav Ferko,Karel Frimmel,Barbora Kalocayova,Rakesh C Kukreja,Antigone Lazou,Lucia Mezesova,Ludmila Okruhlicova,Tanya Ravingerova,Pawan K Singal,Barbara Szeiffova Bacova,Csilla Viczenczova,Norbert Vrbjar,Narcis Tribulova
DOI: https://doi.org/10.1139/cjpp-2017-0121
Abstract:Irradiation of normal tissues leads to acute increase in reactive oxygen/nitrogen species that serve as intra- and inter-cellular signaling to alter cell and tissue function. In the case of chest irradiation, it can affect the heart, blood vessels, and lungs, with consequent tissue remodelation and adverse side effects and symptoms. This complex process is orchestrated by a large number of interacting molecular signals, including cytokines, chemokines, and growth factors. Inflammation, endothelial cell dysfunction, thrombogenesis, organ dysfunction, and ultimate failing of the heart occur as a pathological entity - "radiation-induced heart disease" (RIHD) that is major source of morbidity and mortality. The purpose of this review is to bring insights into the basic mechanisms of RIHD that may lead to the identification of targets for intervention in the radiotherapy side effect. Studies of authors also provide knowledge about how to select targeted drugs or biological molecules to modify the progression of radiation damage in the heart. New prospective studies are needed to validate that assessed factors and changes are useful as early markers of cardiac damage.